HealthQuill Drugs
hospital hygiene
Drugs Health Medical

Scientists find innocuous bacteria cause most hospital infections

HQ Team April 15, 2024: Superbugs are held responsible for most hospital-acquired infections, however, research delving into the genetic data of bacteria causing.

Read More
FoMo has been conceptualised as a negative emotion due to unmet relatedness needs. It may be episodic as in a single conversation or a long-term disposition. Too much exposure to others’ activities results in a feeling of self-doubt and inadequacy — a feeling of “whether I am enough.”
Drugs Health Opinion Pharma

Opinion: FoMo’s ‘compulsive connectivity’ may cause anxiety

By Aparna S April 14, 2024: Social media has remodelled communication in good and bad ways. Those who have been increasingly lonely find.

Read More
Global temperatures associated with climate change may result in a stroke leading to death and disability, a study found.
Climate Drugs Pharma

Global stroke deaths may be linked to climate change: Study reports

HQ Team April 12, 2024: Global temperatures associated with climate change may result in strokes leading to death and disability, a study found..

Read More
Gram-negative, Chlamydia psittaci bacteria
Drugs Health Medical

Chlamydia vaccine shows promise in initial trials

HQ Team April 12, 2024: An early-stage clinical trial for a chlamydia vaccine has shown some positive results, according to a report published.

Read More
Anglo-Swedish drugmaker, AstraZeneca will acquire clinical-stage Fusion Pharmaceuticals for $2 billion in cash to get access to the latter’s radioconjugates to treat cancer.
Drugs Medical Pharma

FDA’s accelerated approval of cancer drugs is hasty and doubtful, says new report

HQ Team April 10, 2024:  A new study has found that cancer drugs that got accelerated approval under the US Federal Drug Approval.

Read More
Synchron, a US-based brain implant company, plans to recruit motor-impaired patients for its clinical trial in competition with Elon Musk’s Neurolink.
Drugs Health Pharma

Rivalling Elon Musk’s Neurolink, Synchron plans brain implant trial 

HQ Team April 9, 2024: Synchron, a US-based brain implant company, plans to recruit motor-impaired patients for its clinical trial in competition with.

Read More
Pfizer Inc., announced its experimental drug for treating a lower respiratory tract disease for adults between 18- to 59 years has met its primary goals in trials.
Drugs Health Pharma

Last-stage trials achieve “positive” results for RSV drug: Pfizer says

HQ Team April 9, 2024: Pfizer Inc., announced its experimental drug for treating a lower respiratory tract disease for adults between 18- to.

Read More
endometriosis
Drugs Health Medical

Oral spray vaccine offers long-term relief against recurrent UTIs

HQ Team April 8, 2024: An oral spray vaccine has proved effective in halting recurrent Urinary Tract Infections (UTIs) for up to nine.

Read More
The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer.
Drugs Health Medical

Rapid cellular aging reason behind early-onset cancers: Scientists

HQ Team April 8, 2024: More cancer cases are being detected among the younger generation, according to a new study presented at the.

Read More
Amylyx Pharmaceuticals announced it has started a process with the USFDA and Health Canada to voluntarily discontinue the marketing authorisations for its amyotrophic lateral sclerosis (ALS) therapy after the drug failed in a last-stage trial.
Drugs Health Pharma

Amylyx Pharma pulls out ALS therapy drug from US, Canada

HQ Team April 4, 2024: Amylyx Pharmaceuticals announced it has started a process with the USFDA and Health Canada to voluntarily discontinue the.

Read More